Call Options

9 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$0.22 - $0.5 $1,672 - $3,800
-7,600 Reduced 10.2%
66,900 $20,000
Q1 2023

May 16, 2023

BUY
$0.36 - $0.63 $1,404 - $2,457
3,900 Added 5.52%
74,500 $27,000
Q4 2022

Feb 14, 2023

BUY
$0.41 - $18.6 $7,134 - $323,640
17,400 Added 32.71%
70,600 $33,000
Q3 2022

Nov 14, 2022

BUY
$0.57 - $34.65 $7,751 - $471,240
13,600 Added 34.34%
53,200 $46,000
Q2 2022

Aug 15, 2022

BUY
$0.85 - $1.41 $6,035 - $10,011
7,100 Added 21.85%
39,600 $37,000
Q1 2022

May 16, 2022

SELL
$1.16 - $2.5 $34,336 - $74,000
-29,600 Reduced 47.67%
32,500 $43,000
Q4 2021

Feb 14, 2022

SELL
$2.46 - $8.74 $98,892 - $351,348
-40,200 Reduced 39.3%
62,100 $153,000
Q3 2021

Nov 15, 2021

BUY
$5.1 - $9.39 $446,249 - $821,625
87,500 Added 591.22%
102,300 $874,000
Q1 2021

May 17, 2021

BUY
$2.01 - $5.55 $29,747 - $82,140
14,800 New
14,800 $66,000

Others Institutions Holding PAVM

# of Institutions
1
Shares Held
2.24M
Call Options Held
0
Put Options Held
0

About PAVmed Inc.


  • Ticker PAVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 90,999,104
  • Market Cap $93.7M
  • Description
  • PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...
More about PAVM
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.